✨ Your Portfolio is fetched and updated from zerodha.
Small Hospitals

Thyrocare Technologies Ltd.

THYROCARE

Market Cap
₹4,790 Cr.
P/E
52.34

Thyrocare Technologies Ltd.

  • Thyrocare Tech.
  • Vimta Labs
  • Krsnaa Diagnostics
  • TJI Diagnostic Chains
FAQs on Thyrocare Technologies Ltd. Shareprice

Thyrocare Tech. has given lower returns compared to its competitors.
Thyrocare Tech. has grown at ~1.49% over the last 3yrs while peers have grown at a median rate of 8.12%

Thyrocare Tech. is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Thyrocare Tech. is 48.99, while 3 year average PE is 44.38.
Also latest EV/EBITDA of Thyrocare Tech. is 23.27 while 3yr average is 25.1.

View FAQ's On Business
Growth Table
  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Balance Sheet
  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Cash Flow
  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Quarterly Results
  • Thyrocare Technologies Ltd.
  • Vimta Labs
  • Krsnaa Diagnostics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Thyrocare Technologies Ltd. Financials

Balance sheet of Thyrocare Tech. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Thyrocare Tech. is increasing.
Latest debt of Thyrocare Tech. is -₹54.48 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹58.07 Crs.

Yes, profit is increasing.
The profit of Thyrocare Tech. is ₹92.32 Crs for TTM, ₹71.05 Crs for Mar 2024 and ₹66.02 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Thyrocare Tech. latest dividend payout ratio is 45.07% and 3yr average dividend payout ratio is 45.07%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech